A(n) <u>anticondon </u>is a group of three bases on trna that is complementary to a specific mrna codon. poly-a tail cap codon anticodon
The main function of an anticondon is to form a pair with the condom by mating in order to form an RNA chain, this chain is a sequence of three nucleotides that form a unit of genetic code in a transfer RNA molecule.
<h3>What is molecule?</h3>
It is the union of two or more atoms by chemical bonds, conserving the physical and chemical properties of that substance.
For example: the water molecule is H2O.
Learn more about molecule at: brainly.com/question/26044300
#SPJ4
He only tested one subject, so his conclusion is not valid.
Answer:
Mitosis may be defined as the process of cell division in which a single diploid parent cell divides into two daughter cells. The four stages of mitosis are prophase, metaphase, anaphase and telophase.
The chromosomes get align at metaphase plate during metaphase. Sometimes the arrangement of chromosomes takes more time and after their alignment anaphase process begins because cells has various checkpoints to maintain the proper cell division. Their improper functioning can cause diseases like cancer. The cells has proper metaphase/ anaphase transitions check point that maintains the proper cell division.
The answer is C, neither the Hawaiian Islands or Mount St. Helen's were created by platonic pressure beneath the ocean. The Mid Atlantic Ridge was formed as the plates slid past each-other, causing on uprising, once again, under the ocean.
Answer:
There is growing evidence to indicate that age-related declines in growth hormone (GH), insulin-like growth factor (IGF)-1, and androgen and estrogen production play a role in the pathogenesis of sarcopenia (an age-related decline in muscle mass and quality). Although GH supplementation has been reported to increase lean body mass in elderly individuals, the high incidence of adverse effects combined with a very high cost has limited the applicability of this form of therapy. The assessment of an alternative approach to enhance the GH/IGF-1 axis in the elderly by using GH-releasing hormone and other secretagogues is currently under way and is showing some promise. Testosterone replacement therapy may increase muscle mass and strength and decrease body fat in hypogonadal elderly men. Long-term randomised, controlled trials are needed, however, to better define the risk-benefit ratio of this form of therapy before it can be recommended. Available data are currently insufficient to decide what role estrogen replacement therapy may play in the management of sarcopenia. Therefore, although the evidence linking age-related hormonal changes to the development of sarcopenia is rapidly growing, it is still too early to determine the clinical utility of hormonal supplementation in the management of sarcopenia.
